Financhill
Back

Biogen, Inc. Stock Predictions

Biogen, Inc. Stock Forecast

  • Over the next 52 weeks, Biogen, Inc. has on average historically risen by 34.2% based on the past 34 years of stock performance.
  • Biogen, Inc. has risen higher in 18 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.94%
  • Is Biogen, Inc. Stock Undervalued?
    The current Biogen, Inc. [BIIB] share price is $164.68. The Score for BIIB is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Biogen, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Biogen, Inc. has on average historically risen by 34.2% based on the past 34 years of stock performance.

Biogen, Inc. Stock Rating

Buy
56
Biogen, Inc. (BIIB) is a Buy

Is Biogen, Inc. overpriced?

  • Biogen, Inc. has risen higher in 18 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.94%

Biogen, Inc. Stock Price History

Is BIIB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com

52-Week Data

52-Week High:
169.00
52-Week Low:
110.04

Prediction Charts

Market Cap:
24.2B
Price in USD:
164.68
Volume:
2.2M
Beta:
0.86

Technical Analysis

SMA50:
148.83
SMA100:
140.77
SMA200:
136.01
52-Wk Change:
2.93%

Stock Predictions

  • Is Biogen, Inc. stock public?
    Yes, Biogen, Inc. is a publicly traded company.
  • What is the Biogen, Inc. stock quote today?
    The Biogen, Inc. stock price is 164.68 USD today.
  • How to buy Biogen, Inc. stock online?
    You can buy Biogen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 148.82 147.86 149.91 147.54
Oct-30 140.10 149.61 154.44 138.00
Oct-31 147.99 154.27 155.18 146.52
Nov-3 153.60 151.44 155.33 149.63
Nov-4 150.89 149.33 152.90 149.05
Nov-5 149.66 153.43 153.68 148.51
Nov-6 155.76 156.74 157.80 153.76
Nov-7 156.70 155.51 156.70 151.83
Nov-10 155.41 156.26 156.55 153.77
Nov-11 156.76 159.56 159.95 154.20
Nov-12 160.00 161.48 162.56 158.05
Nov-13 161.57 164.73 167.87 161.20
Nov-14 164.72 167.55 169.00 163.00
Nov-17 167.00 164.68 167.97 163.50

Biogen, Inc. Earnings

Biogen, Inc. Earnings Report: Per Share Biogen, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Biogen, Inc. Forecast Revenue Growth

Biogen, Inc. Stock Analysis: Historical quarterly revenues per share for Biogen, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.14 per share.

* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.